wire - news in brief

« BACK

Administration/Government



Results 1 - 50 of 186.
1 2 3 4 Next »


Administration / Government - 28.06.2018
Ln vitro Cortical Network Firing is Homeostatically Regulated : A Model for Sleep Regulation - News
ln vitro Cortical Network Firing is Homeostatically Regulated : A Model for Sleep Regulation Sohrab Saberi-Moghadam, Alessandro Simi, Hesam Setareh, Cyril Mikhail & Mehdi Tafti Prolonged wakefulness

Medicine / Pharmacology - Administration / Government - 01.06.2018

Administration / Government - Medicine / Pharmacology - 30.05.2018

Administration / Government - Careers / Employment - 15.05.2018
Competitive funding by the SNSF promotes high-quality research
Competitive funding by the SNSF promotes high-quality research
In 2017, the Swiss National Science Foundation (SNSF) invested in 2971 new projects. Each project had to undergo a stringent evaluation process in which it was rated relative to competing projects.

Administration / Government - Innovation / Technology - 15.05.2018

Administration / Government - 03.05.2018

Medicine / Pharmacology - Administration / Government - 30.04.2018
Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma
Tafinlar + Mekinist is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection  

Medicine / Pharmacology - Administration / Government - 19.04.2018

Medicine / Pharmacology - Administration / Government - 16.04.2018
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes Heart failure (HF) patients with reduced

Life Sciences - Administration / Government - 10.04.2018
Researcher Granted EUR 2.5 Million in Funding
Each year the European Research Council (ERC), open to both junior and established researchers, awards substantial funding for outstanding fundamental research.

Administration / Government - Business / Economics - 09.03.2018

Innovation / Technology - Administration / Government - 07.03.2018
Connected vehicle tech: Mandate now to save lives
ANN ARBOR-Up to 8.1 million car crashes and 44,000 deaths could be prevented if the federal government mandated connected vehicle technology now, rather than waiting even three years to develop and evaluate competing technologies.

Innovation / Technology - Administration / Government - 05.03.2018

Medicine / Pharmacology - Administration / Government - 27.02.2018
European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors
European Commission approves Roche's Hemlibra for people with haemophilia A with inhibitors First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra d

Innovation / Technology - Administration / Government - 27.02.2018

Medicine / Pharmacology - Administration / Government - 14.02.2018

Medicine / Pharmacology - Administration / Government - 13.02.2018
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis Glatopa 40 mg/mL is a fully substitutable, AP-rated generic

Environment - Administration / Government - 29.01.2018
Calculating the CO2 emissions of biofuels is not enough
A new EU regulation aims to shrink the environmental footprint of biofuels starting in 2021. But an EPFL scientist thinks we should go one step further and take into account all compounds produced at biorefineries, not just biofuel.

Medicine / Pharmacology - Administration / Government - 26.01.2018
Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
Lutathera marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)   Advanced Accelerator Applications is a newly established subsidiary of Novartis   Lutathera expands Novartis' n

Administration / Government - Innovation / Technology - 23.01.2018

Astronomy / Space Science - Administration / Government - 17.01.2018
Investigation launched
ETH Zurich's Executive Board has launched an investigation into allegations of research misconduct by a professor in the former Institute for Astronomy.

Administration / Government - Careers / Employment - 04.01.2018

Medicine / Pharmacology - Administration / Government - 22.12.2017
Novartis’ combination therapy Tafinlar + Mekinist granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma
Novartis' combination therapy Tafinlar + Mekinist granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma Priority Review designation based on Phase I

Law / Forensics - Administration / Government - 11.12.2017
Ontario Should Revise Discriminatory Policy Against Refugee Drivers
Allow experienced drivers from war-torn countries to skip driving-test waiting period similar to other newcomers in Ontario Toronto, ON - Ontario's Ministry of Transportation should revise its policy

Medicine / Pharmacology - Administration / Government - 06.12.2017
Personalized Health: National Funding for Basel-led Research Groups
Personalized Health: National Funding for Basel-led Research Groups
Nine research projects involving Basel-based researchers in the field of personalized health are to receive funding from the Swiss government: support will be given to researchers from the University

Administration / Government - Physics / Materials Science - 22.11.2017
Driving into danger with the blue lights flashing
The PSI radiation protection service is responsible for missions not only at the Institute, but throughout the canton of Aargau.

Medicine / Pharmacology - Administration / Government - 15.11.2017
Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania
Objective is to provide patients with rapid cancer diagnostics and appropriate care First focus will be on Ethiopia, Uganda and Tanzania Cancer is on the rise in Africa, with more than 500,000 deaths

Innovation / Technology - Administration / Government - 15.11.2017

Medicine / Pharmacology - Administration / Government - 11.11.2017
Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases
Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access Punjab government will make m

Medicine / Pharmacology - Administration / Government - 01.11.2017
Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting
Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting Further results from emicizumab phase III studies in people with haemophilia

Administration / Government - Astronomy / Space Science - 25.10.2017
Administrative enquiry opened
ETH Zurich is launching an administrative enquiry into allegations made in the Department of Physics.

Medicine / Pharmacology - Administration / Government - 23.10.2017
Novartis combination adjuvant therapy Tafinlar + Mekinist receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients
Novartis combination adjuvant therapy Tafinlar + Mekinist receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients Breakthrough Therapy Designation ba

Medicine / Pharmacology - Administration / Government - 10.10.2017

Medicine / Pharmacology - Administration / Government - 06.10.2017
FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus
FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus Zika virus infection is linked to neurological complications in adults, and brain defects in fetuses

Environment - Administration / Government - 06.10.2017
Instrument of ratification deposited: Paris climate agreement to enter into force for Switzerland on 5 November 2017
Bern, 06.10.2017 - Switzerland deposited its instrument of ratification in New York on 6 October 2017, making it an official party to the Paris Agreement.

Mathematics - Administration / Government - 05.10.2017

Administration / Government - 29.09.2017

Medicine / Pharmacology - Administration / Government - 22.09.2017
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
CMLPath to Care(TM) collaboration replaces Glivec International Patient Access Program (GIPAP) with a new, independent, patient-centered access model   GIPAP was introduced 15 years ago and has provi

Administration / Government - Agronomy / Food Science - 29.08.2017

Administration / Government - Medicine / Pharmacology - 23.08.2017
Switzerland once again a full member of partnership-funded EU innovation programmes
Bern, 23.08.2017 - On 23 August, the Federal Council approved the agreements on Switzerland's participation in the Eurostars-2 and the Active and Assisted Living research and development programmes.

Business / Economics - Administration / Government - 15.08.2017
The smart grid analysts
The smart grid analysts
ETH spin-off Adaptricity has developed a piece of software that can be used to analyse the increasingly intelligent power grids.

Administration / Government - 11.07.2017
Use-inspired basic research: external report recommends targeted adjustments
Use-inspired basic research: external report recommends targeted adjustments
The Swiss National Science Foundation (SNSF) commissioned an external evaluation of its funding category "use-inspired basic research" last year. Based on the evaluators' recommendations, it has now decided to introduce targeted changes in its processes. Based on a mandate from the federal government, the Swiss National Science Foundation promotes scientific research; the focus is on basic research.

Medicine / Pharmacology - Administration / Government - 10.07.2017
Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine
Positive phase III results for Roche's emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate by 79% compared to prior prophylactic bypassing agents Data from HAVEN 1 in adults and adolescents and inte

Administration / Government - Careers / Employment - 06.07.2017
Ten years of the European Research Council: positive record from Swiss perspective
Bern, 06.07.2017 - An event was held in Geneva on 6 July to mark the tenth anniversary of the European Research Council (ERC).

Medicine / Pharmacology - Administration / Government - 27.06.2017
Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)
Fewer pills, more flexibility in dosing: Roche's new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of
1 2 3 4 Next »